Skip to content
healthcare.dev

Ipratropium Bromide Inhalation

NDC 17270-0401, Ipratropium Bromide Inhalation, aerosol, from Armstrong Pharmaceuticals, Inc..

Product NDC
17270-0401
Status
Listed
Labeler
Armstrong Pharmaceuticals, Inc.
Dosage form
AEROSOL
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217953
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17270-0401 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IPRATROPIUM BROMIDE17 ug/1

Pharmacologic classes

Anticholinergic [EPC]; Cholinergic Antagonists [MoA]

Package NDCNDC-11Package
17270-0401-0172700401001 CANISTER in 1 CARTON (17270-0401-0) / 200 AEROSOL in 1 CANISTER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/133cc2ed-f018-4295-b84e-b24382299360
  • NADAC price for package 17270040100

    GET /v1/drugs/nadac/17270040100

Use it

Look up 17270-0401 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17270-0401 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17270-0401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.